rs748531024
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004928.3(CFAP410):c.33_34insAGCTGCACAGCGTGCA(p.Ala12SerfsTer60) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00008 in 1,474,772 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R11R) has been classified as Benign.
Frequency
Consequence
NM_004928.3 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP410 | NM_004928.3 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | 1/7 | ENST00000339818.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP410 | ENST00000339818.9 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | 1/7 | 1 | NM_004928.3 | P4 | |
CFAP410 | ENST00000325223.7 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | 1/7 | 1 | A1 | ||
CFAP410 | ENST00000397956.7 | c.33_34insAGCTGCACAGCGTGCA | p.Ala12SerfsTer60 | frameshift_variant | 1/7 | 1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000790 AC: 12AN: 151840Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000436 AC: 4AN: 91818Hom.: 0 AF XY: 0.0000388 AC XY: 2AN XY: 51562
GnomAD4 exome AF: 0.0000801 AC: 106AN: 1322932Hom.: 0 Cov.: 32 AF XY: 0.0000736 AC XY: 48AN XY: 652506
GnomAD4 genome ? AF: 0.0000790 AC: 12AN: 151840Hom.: 0 Cov.: 31 AF XY: 0.0000674 AC XY: 5AN XY: 74176
ClinVar
Submissions by phenotype
not provided Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 20, 2020 | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Observed with a second pathogenic variant in a patient with retinitis pigmentosa in published literature (Carss et al., 2017), although the phase of these two variants was not confirmed; This variant is associated with the following publications: (PMID: 32581362, 28041643) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | CFAP410: PVS1, PM2 - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Jul 20, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 438159). This premature translational stop signal has been observed in individuals with retinal dystrophy (PMID: 28041643). This variant is present in population databases (rs748531024, gnomAD 0.02%). This sequence change creates a premature translational stop signal (p.Ala12Serfs*60) in the CFAP410 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CFAP410 are known to be pathogenic (PMID: 23105016, 26167768). - |
Retinal dystrophy Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 09, 2019 | - - |
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Retinitis pigmentosa Pathogenic:2
Pathogenic, criteria provided, single submitter | research | Ophthalmic Genetics Group, Institute of Molecular and Clinical Ophthalmology Basel | Jul 24, 2023 | Clinical significance based on ACMG v2.0 - |
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at